Correlation Between Sedana Medical and CellaVision

Can any of the company-specific risk be diversified away by investing in both Sedana Medical and CellaVision at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sedana Medical and CellaVision into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sedana Medical AB and CellaVision AB, you can compare the effects of market volatilities on Sedana Medical and CellaVision and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sedana Medical with a short position of CellaVision. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sedana Medical and CellaVision.

Diversification Opportunities for Sedana Medical and CellaVision

0.55

Correlation Coefficient

Sedana Medical  CellaVision

Very weak diversification

The 3 months correlation between Sedana and CellaVision is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding Sedana Medical AB and CellaVision AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CellaVision AB and Sedana Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sedana Medical AB are associated (or correlated) with CellaVision. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CellaVision AB has no effect on the direction of Sedana Medical i.e., Sedana Medical and CellaVision go up and down completely randomly.

Pair Corralation between Sedana Medical and CellaVision

Assuming the 90 days trading horizon Sedana Medical AB is expected to generate 1.11 times more return on investment than CellaVision. However, Sedana Medical is 1.11 times more volatile than CellaVision AB. It trades about 0.18 of its potential returns per unit of risk. CellaVision AB is currently generating about 0.04 per unit of risk. If you would invest  1,010  in Sedana Medical AB on April 24, 2025 and sell it today you would earn a total of  450.00  from holding Sedana Medical AB or generate 44.55% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Sedana Medical AB  vs.  CellaVision AB

Sedana Medical AB

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Sedana Medical AB are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain fundamental indicators, Sedana Medical sustained solid returns over the last few months and may actually be approaching a breakup point.

CellaVision AB

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in CellaVision AB are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, CellaVision may actually be approaching a critical reversion point that can send shares even higher in August 2025.

Pair Trading with Sedana Medical and CellaVision

The main advantage of trading using opposite Sedana Medical and CellaVision positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sedana Medical position performs unexpectedly, CellaVision can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CellaVision will offset losses from the drop in CellaVision's long position.

The idea behind Sedana Medical AB and CellaVision AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.